| CRIS Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CRIS shares outstanding history going back to 5/30/2018:
Also see: CRIS Market Cap History CRIS YTD Return |

| CRIS Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CRIS shares outstanding history going back to 5/30/2018:
Also see: CRIS Market Cap History CRIS YTD Return |
| CRIS Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CRIS Historical Shares Outstanding: +37.23% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CRIS Stock Price Chart |
| About Curis Inc |
| Curis, Inc. is a biotechnology company. Co. is focused on the development of emavusertib (CA-4948), an orally available, small molecule inhibitor of Interleukin-1 receptor associated kinase (IRAK4). Emavusertib is undergoing testing in the Phase I/II TakeAim Lymphoma study in patients with relapsed/refractory primary central nervous system lymphoma (PCNSL) in combination with the BTK inhibitor ibrutinib, as a monotherapy in the Phase I/II TakeAim Leukemia study in patients with relapsed/refractory acute myeloid leukemia (AML) and relapsed/refractory high risk myelodysplastic syndrome (hrMDS). Its other clinical programs include Fimepinostat and CA-170. We show 33 historical shares outstanding datapoints in our coverage of CRIS's shares outstanding history. Understanding the changing numbers of CRIS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CRIS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CRIS by allowing them to research CRIS shares outstanding history as well as any other stock in our coverage universe. |
| CRIS Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| CRIS Share Performance |
| Shares Outstanding Peers |
| Curis (CRIS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CRL Shares Outstanding History CRMD Shares Outstanding History CRNX Shares Outstanding History CRTX Shares Outstanding History CRVL Shares Outstanding History CRVO Shares Outstanding History CRVS Shares Outstanding History CRY Shares Outstanding History CSBR Shares Outstanding History CSII Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.